Table 3.
Antiangiogenic effects of extracts or bioactive constituents of Phyllanthus urinaria.
Extract/bioactive constituent | Cancer type | Study type | Mechanism | Reference |
---|---|---|---|---|
Aqueous | Mice bearing Lewis lung carcinoma cells, HUVECs | In vivo and in vitro | Suppressed neovascularization in mice | [68] |
Aqueous and methanolic | MeWo and PC-3HUVECs | In vitro | Suppressed of migration, invasion, and microcapillary like-tube structure formation in HUVECs | [69] |
Aqueous | Human osteosarcoma xenograft mice | In vivo | Inhibition of cluster of differentiation 31 | [70] |
Ellagic acid | Chorioallantoic membrane in chicken embryo | In vivo | Inhibition of MMP-2 | [71] |
Methanolic | Male Sprague-Dawley rats, HUVECs | In vivo and in vitro | Suppression of vascular growth and tube formation | [72] |
Aqueous | Hepatocellular carcinoma | In vivo and in vitro | Inhibition of migration | [73] |